These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14146538)

  • 1. [EFFECT OF DOSAGE FORMS ON THE RESORPTION OF DRUGS].
    FINHOLT P
    Sven Farm Tidskr; 1964 May; 68():345-51 CONCL. PubMed ID: 14146538
    [No Abstract]   [Full Text] [Related]  

  • 2. HOW DRUGS ACT. I. HOW DRUGS ARE ABSORBED.
    SMITH SE
    Nurs Times; 1963 Sep; 59():1106-8. PubMed ID: 14049093
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of gonadotropin-releasing hormone and its analogs.
    Handelsman DJ; Swerdloff RS
    Endocr Rev; 1986 Feb; 7(1):95-105. PubMed ID: 3007081
    [No Abstract]   [Full Text] [Related]  

  • 4. Biopharmaceutical considerations in subcutaneous and intramuscular drug administration.
    Ballard BE
    J Pharm Sci; 1968 Mar; 57(3):357-78. PubMed ID: 4871917
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in pharmaceutical technology in 1966-1967. II. Drugs and pharmaceutical preparations].
    Chalabala M; Malý J; Burelová A; Starha L; Heliová M; Rak J; Rehula A
    Cesk Farm; 1968 Nov; 17(9):450-61. PubMed ID: 4888356
    [No Abstract]   [Full Text] [Related]  

  • 6. Microscopic evidence of lymphogenic absorption of oil in humans receiving neuroleptic oily depot preparations intramuscularly.
    Svendsen O; Dencker SJ; Fog R; Gravem AO; Kristjansen P
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):157-8. PubMed ID: 6108046
    [No Abstract]   [Full Text] [Related]  

  • 7. [RISTOCETIN, KANAMYCIN, FARMIGLUCIN. CHARACTERISTICS, ANTIBACTERIAL SPECTRUM, ABSORPTION, ELIMINATION AND HEMATIC AND URINARY CONCENTRATIONS AFTER DIFFERENT METHODS OF ADMINISTRATION].
    VELLUCCI A; TALLARIDA G; PIERANGELI L; DONATI G
    Gazz Int Med Chir; 1964 Nov; 68():2002-6. PubMed ID: 14240883
    [No Abstract]   [Full Text] [Related]  

  • 8. THE RELATION BETWEEN METHOD OF ADMINISTRATION, ROUTE OF ABSORPTION, INHIBITORY ACTIONS AND ACUTE TOXICITY OF ARECOLINE HYDROBROMIDE IN DOGS.
    FORBES LS
    Ann Trop Med Parasitol; 1964 Jun; 58():119-31. PubMed ID: 14183097
    [No Abstract]   [Full Text] [Related]  

  • 9. DOSAGE FORMS FOR USE IN ORAL THERAPEUTICS.
    BERNSTEIN HB; SCHEINDLIN S
    J Oral Ther Pharmacol; 1964 Jul; 1():99-105. PubMed ID: 14204422
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of the polyethylene glycols as vehicles for intramuscular and subcutaneous Injection.
    CARPENTER CP; SHAFFER CB
    J Am Pharm Assoc Am Pharm Assoc; 1952 Jan; 41(1):27-9. PubMed ID: 14907489
    [No Abstract]   [Full Text] [Related]  

  • 11. [CLINICAL STUDY OF A DELAYED FORM OF TERRAMYCIN IN SOLUTION READY TO USE FOR INTRAMUSCULAR INJECTION].
    MORETTI G; STAEFFEN J
    Sem Hop; 1963 Oct; 39():2182-4. PubMed ID: 14134267
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained release veterinary parenteral products.
    Medlicott NJ; Waldron NA; Foster TP
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1345-65. PubMed ID: 15191786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterile topical dosage forms. I. Laboratory phase.
    Polli GP; Fong DT; Shoop CE
    J Pharm Sci; 1972 Jul; 61(7):1078-80. PubMed ID: 4625585
    [No Abstract]   [Full Text] [Related]  

  • 14. [USE OF A NEW DELAYED-ACTION SULFONAMIDE IN THE TREATMENT OF CEREBROSPINAL MENINGITIS BY A SINGLE MEDICAMENTOUS INJECTION].
    BARBOTIN M; NGUYEN TRUNG-LUONG
    Presse Med (1893); 1964 Nov; 72():2923. PubMed ID: 14213758
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the absorption of practically water-insoluble drugs following injection. IV. An approach for predicting relative intramuscular absorption rates of a drug in oily solution, aqueous suspension and aqueous surfactant solution in rats.
    Hirano K; Yamada H
    Chem Pharm Bull (Tokyo); 1981 May; 29(5):1410-5. PubMed ID: 7296708
    [No Abstract]   [Full Text] [Related]  

  • 16. [CONTRIBUTION TO THE STUDY OF A TEST FOR THE MICROBIOLOGICAL CONTROL OF THE PRESERVATION OF VARIOUS GALENICAL FORMS (SYRUPS, DROPS, OINTMENTS).I].
    BARBEROT R; PINZON R; MIRIMANOFF A
    Pharm Acta Helv; 1964 Sep; 39():556-64. PubMed ID: 14224310
    [No Abstract]   [Full Text] [Related]  

  • 17. [New formulations to be used in dental pharmacology].
    Korbar-Smid J; Sumer-Toldi D
    Zobozdrav Vestn; 1980; 35(5-6):179-83. PubMed ID: 6943878
    [No Abstract]   [Full Text] [Related]  

  • 18. A study on the mode of administration of thyrotropin releasing hormone (TRH) in mice.
    Redding TW; Schally AV
    Neuroendocrinology; 1970; 6(5):329-35. PubMed ID: 4991575
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral and parenteral formulations of marijuana constituents.
    Rosenkrantz H; Thompson GR; Braude MC
    J Pharm Sci; 1972 Jul; 61(7):1106-12. PubMed ID: 4625586
    [No Abstract]   [Full Text] [Related]  

  • 20. [R OLE OF THE VEHICLE IN LOCAL TREATMENT OF THE EYE].
    NORN MS
    Dan Tidsskr Farm; 1964 May; 38():95-103. PubMed ID: 14153438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.